Contrast agents to target extracellular matrix

Details for Australian Patent Application No. 2005307195 (hide)

Owner GE Healthcare AS

Inventors Healey, Andrew; Eriksen, Morten; Lovhaug, Dagfinn; Fjerdingstad, Hege B.

Agent Davies Collison Cave

Pub. Number AU-A-2005307195

PCT Pub. Number WO2006/054904

Priority 20045081 22.11.04 NO

Filing date 21 November 2005

Wipo publication date 26 May 2006

International Classifications

A61K 49/00 (2006.01) Preparations for testing

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/054904 Priority application(s): WO2006/054904

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005307197-An information system

2005307194-Method of cardiac imaging with the use of hyperpolarized 13 C-pyruvate